Well being minister Dr Zweli Mkhize says that the following batch of Johnson & Johnson vaccines will arrive within the nation this weekend, taking the full doses in South Africa for part one of many rollout to 160,000.
The primary batch of vaccines noticed 80,000 doses delivered on 16 February, with the identical variety of healthcare employees anticipated to be vaccinated two weeks after the drop. The official rollout began on 17 February.
Presenting to parliament on Tuesday (23 February), Mkhize mentioned that the nation is on track to finish the primary 40,000 of those vaccinations by Wednesday (24 February) – one week later.
He added that the following batch of 80,000 doses of Johnson & Johnson vaccines will arrive this Saturday, 27 February 2021.
Commenting on the federal government’s vaccine technique up till now, Mkhize mentioned that South Africa was ‘by no means asleep’.
“We selected a technique that was guided by science as we didn’t have the monetary muscle to make unhedged bets. Our strategy has paid off as we’ve got been capable of be nimble and exact across the difficult concern of the variant.
The well being minister added that the procurement of the vaccines has been a fancy course of that required negotiations with multinational producers of vaccines within the face of vaccine nationalism and protectionism.
He mentioned that is primarily as a result of the richer international locations have utilised their monetary muscle to acquire vaccines on threat and much in extra of what they want.
Mkhize mentioned it was for that reason that authorities opted to diversify its strategy to vaccines procurement by partaking by way of varied mechanisms – bilaterally by way of steady engagements with particular person producers; multilaterally by way of the COVAX facility and regionally by way of the African Union’s Vaccine Financing and Vaccine Acquisition Activity Crew.
“Now we have signed Non-Disclosure Agreements with many of the main producers. This permits us to achieve crucial perception into their provide traces, their manufacturing plans and potential blockages within the manufacturing pipeline.
“It additionally permits us to pursue negotiations over costs, volumes and timelines for supply,” Mkhize mentioned.
“By pursuing vaccination below the Sisonke Protocol, which allowed us to make use of the Johnson & Johnson batches that had already been licensed by SAHPRA below analysis circumstances, we can be considered one of only a few nations that undertakes a well-designed affect evaluation as we rollout vaccines to our well being care employees.”
Citing knowledge from the Human Science Analysis Council, Mkhize mentioned that 67% of residents would both undoubtedly take the vaccine or would most likely take the vaccine and solely 12% mentioned they’d not take the vaccine.
“This proof assured us that the excessive degree of vaccine hesitancy that was presupposed to threaten our means to roll out vaccines was really not true,” Mkhize mentioned. “To this point, there have been nearly 500,000 registrations on the EVDS system.”
Mkhize additionally confirmed that South Africa will promote its Astra Zeneca Covid-19 inventory to the African Union at price value.